Industries such as textiles, polymers, pharmaceuticals, papers, and tanneries are the key contributors to the global economy. These industries utilize various types of synthetic dyes in their processes, leading to discharge of dyes-contaminated wastewater. The wastewater generally contains various types of dyes (such as methyl orange, congo red, malachite green, etc.), which have a detrimental impact on the ecosystem and human health due to their toxic, carcinogenic, and mutagenic nature. As the result, it is crucial to treat the dyes-contaminated wastewater to protect the environment and render it suitable for reuse, mitigating the escalating global demand for clean water. This review provides a comprehensive overview of dyes and their treatment technologies (i.e., physical, chemical, and biological treatment). Among various treatment methods, the biological treatment is widely employed due to its energy efficiency and eco-friendliness. However, biological treatment faces challenges such as slow processing rates and limited effectiveness in handling low-biodegradability pollutants (BOD/COD <0.2). This review also highlighted recent advancements in treatment technologies and explored the emerging integrated treatment method that aims to achieve higher removal efficiency for a low biodegradability index dye-contaminated wastewater. Additionally, a techno-economic assessment is presented, analyzing the cost-effectiveness of the emerging technologies in real-world applications. Further, the critical research gaps and future outlooks are also discussed. Overall, the review aims to contribute to the ongoing efforts to improve wastewater treatment processes and promote sustainable water management practices.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1016/j.jenvman.2024.122804 | DOI Listing |
Int J Surg
January 2025
Department of Anorectal Surgery, Shuguang Hospital, Shanghai University of Traditional Chinese Medicine, Shanghai, China.
Background: Crohn's disease (CD) is a chronic, recurrent gastrointestinal disorder characterized by a complex etiology. Among its perianal complications, anal fistulas represent a challenging comorbidity. With the increase of surgical options, a comprehensive bibliometric analysis was deemed necessary to consolidate the vast array of research in this field.
View Article and Find Full Text PDFACS Biomater Sci Eng
January 2025
J. Crayton Pruitt Family Department of Biomedical Engineering, University of Florida, Gainesville, Florida 32611, United States.
The complexation of nucleic acids and collagen forms a platform biomaterial greater than the sum of its parts. This union of biomacromolecules merges the extracellular matrix functionality of collagen with the designable bioactivity of nucleic acids, enabling advances in regenerative medicine, tissue engineering, gene delivery, and targeted therapy. This review traces the historical foundations and critical applications of DNA-collagen complexes and highlights their capabilities, demonstrating them as biocompatible, bioactive, and tunable platform materials.
View Article and Find Full Text PDFJAMA Pediatr
January 2025
Division of Nephrology, The Hospital for Sick Children, Toronto, Ontario, Canada.
Importance: Cyclophosphamide and calcineurin inhibitors are the most used nonsteroid immunosuppressive medications globally for children with various chronic inflammatory conditions. Their comparative effectiveness remains uncertain, leading to worldwide practice variation. Nephrotic syndrome is the most common kidney disease managed by pediatricians globally and suboptimal treatment is associated with high morbidity.
View Article and Find Full Text PDFClin Cancer Res
January 2025
Massachusetts General Hospital Cancer Center, Boston, MA, United States.
Background: Race/ethnicity may affect outcomes in metastatic breast cancer (MBC) due to biological and social determinants. We evaluated the impact of race/ethnicity on clinical, socioeconomic, and genomic characteristics, clinical trial participation, and receipt of genotype-matched therapy among patients with MBC.
Methods: A retrospective study of patients with MBC who underwent cell-free DNA testing (cfDNA, Guardant360â, 74 gene panel) between 11/2016 and 11/2020 was conducted.
Invest New Drugs
January 2025
School of Life Sciences, Jilin University, Changchun, China.
Due to the emergence of drug resistance, androgen receptor (AR)-targeted drugs still pose great challenges in the treatment of prostate cancer, and it is urgent to explore an innovative therapeutic strategy. MK-1775, a highly selective WEE1 inhibitor, is shown to have favorable therapeutic benefits in several solid tumor models. Recent evidence suggests that the combination of MK-1775 with DNA-damaging agents could lead to enhanced antitumor efficacy.
View Article and Find Full Text PDFEnter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!